Skip navigation

Alexion Pharmaceuticals Inc.

NMS : ALXN
Chemicals
Cheshire CT
2013 Revenue (US$ Millions)$1,551
2012 Revenue (US$ Millions)$1,134
Revenue Growth (%)36.79%
Net Income (US$ Millions)$253
Common Shares Outstanding (Millions)$197
Earnings Per Share (US$)$1.27
Price To Earnings Ratio132.91
Total Equity (US$ Millions)$2,382
Profit Margin (%)16.30%
Return On Equity (%)12.83%
Long Term Debt (US$ Millions)$97
Debt To Equity Ratio (%)0.04%
Market Capitalization (US$ Millions)$26,172
Total Assets (US$ Millions)$3,318
Return on Assets (%)9.68
Current Assets (US$ Millions)$2,187
Inventories (US$ Millions)$103
Current Liabilities (US$ Millions)$582
Cost of Goods Sold (US$ Millions)$178
Asset Turnover0.47
Inventory Turnover1.8
ExchangeNMS